Seacoast Banking Corporation of Florida filings document the regulatory record of a Florida bank holding company whose principal operating subsidiary is Seacoast National Bank. Its 8-K reports furnish quarterly and annual results, investor presentations, Regulation FD materials, securities-portfolio actions and other material events tied to bank earnings, deposits, net interest income, capital and liquidity.
Proxy and governance filings describe annual meeting matters, board composition, director elections, compensation and shareholder voting items. Transaction and capital-structure disclosures document completed bank acquisitions, amendments related to Series A Non-Voting Preferred Stock, rights of security holders and other matters affecting Seacoast's common and preferred equity.
Seacoast Banking Corp. of Florida (SBCF) director Dennis S. Hudson III sold 1,000 shares of common stock on November 9, 2026, at $34.31 per share; the shares were held in an IRA. The report also lists direct rights to buy 55,279 shares at $31.15, expiring April 2, 2028, and 78,021 shares at $28.69, expiring April 3, 2027. The rights vest over three years in one-third increments beginning on the first grant anniversary, subject to continuous employment and the company's banking subsidiary meeting certain capital requirements.
Seacoast Banking Corporation of Florida reported third-quarter 2026 net income of $59.9 million, or $0.55 per diluted share; adjusted net income was $71.8 million, or $0.66 per share. Net income rose 64% and adjusted net income 59% from the year-earlier quarter. Net interest income was $185.4 million, up 2% from the prior quarter; net interest margin was 3.83%, and margin excluding accretion on acquired loans was 3.66%. Adjusted measures are non-GAAP.
Loans increased by $429 million, a 13% annualized rise during the quarter. Deposits were $16.6 billion at September 30, 2026, compared with $16.8 billion at June 30, 2026. Available-for-sale securities unrealized losses increased $237.0 million during the quarter; tangible book value per share was $15.96 at September 30, compared with $17.25 at June 30. The 2026 outlook lists 28%-31% growth in adjusted revenue on a fully taxable equivalent basis, diluted adjusted EPS of $2.48-$2.52, and high-single-digit organic loan growth.
Seacoast Banking Corporation of Florida (SBCF) reported third-quarter 2026 net income of $59.9 million, or $0.55 per diluted share, up 64% from $36.5 million a year earlier. Net interest income reached $183.4 million, up 37% year over year, primarily reflecting higher loan and securities balances following 2025 acquisitions. For the first nine months, net income was $151.3 million versus $110.6 million.
Organic loans grew at a 13% annualized rate in the third quarter. Net interest margin was 3.83%, unchanged from the prior quarter, while the cost of deposits rose to 1.60% from 1.53%. The company completed integration of Villages Bancorporation in the third quarter and repurchased more than 1.2 million common shares year to date.
Nine-month net securities losses were $40.126 million, versus $0.606 million in 2025, including $39.6 million of gross losses on securities sales. Third-quarter other comprehensive loss was $176.1 million, reflecting $180.0 million in after-tax unrealized losses on available-for-sale securities; management attributed the specified debt-security losses to rate and spread movements and said it expects to recover their amortized cost.
Seacoast Banking Corp of Florida (SBCF) EVP & CFO Tracey Dexter exercised options for 300 common shares on November 2, 2026, in a cash exercise at $31.15 per share. The reported market price that date was $34.00. After the transaction, 892 common-stock rights to buy remained; those rights expire April 1, 2028.
Seacoast Banking Corporation of Florida (SBCF) reported third-quarter 2026 net income of $59.9 million, or $0.55 per diluted share, up 64% from a year earlier. Adjusted net income, a non-GAAP measure, was $71.8 million, up 59%; net revenues were $215.0 million, up 37%; and GAAP net interest income was $183.4 million, up 37%. Organic loans grew at a 13% annualized rate, with loan balances increasing $428.8 million during the quarter.
At September 30, 2026, total assets were $21.2 billion, deposits were $16.6 billion and the Tier 1 capital ratio was 14.1%. Nonperforming loans totaled $73.3 million, or 0.54% of loans, down from $86.5 million in June but above $60.6 million a year earlier. Noninterest expense rose 31% year over year to $133.3 million, including $15.5 million in merger and integration costs. Tangible book value per share, treating convertible preferred shares as common, was $15.96 versus $17.25 in June; Seacoast said higher rates and wider spreads affecting accumulated other comprehensive income contributed approximately $1.63 to the quarterly decline.
Seacoast Banking Corp of Florida reported that H. Gilbert Culbreth Jr., identified as Director of Subsidiary, acquired 387 common shares on October 8, 2026, in an award held in Seacoast's Non-employee Directors Deferred Compensation Plan. The transaction lists $31.97 per share. Separate reported holdings include a direct right to buy 2,142 common shares at a $22.65 exercise price, expiring February 6, 2027, plus 26,000 shares held through a family limited liability company and 8,200 through a family sub-S corporation as of October 8, 2026.
SEACOAST BANKING CORP OF FLORIDA (SBCF) director Dennis S. Hudson III reported selling 12,000 shares of Common Stock on September 16, 2026 at a weighted average price of $34.15 per share, in multiple trades between $33.99 and $34.27, under a Rule 10b5-1 trading plan adopted on November 21, 2025.
He continues to have indirect ownership of 21,867 shares held by his spouse in trust and 51,416 shares held by Sherwood Partners, Ltd., a family partnership, and holds stock options covering 55,279 shares at $31.15 and 78,021 shares at $28.69 that are scheduled to expire in 2028 and 2027, respectively.
SEACOAST BANKING CORP OF FLORIDA (SBCF) is the issuer of common stock for which a Form 144 notice has been filed on behalf of the Dennis S. Hudson III Revocable Trust U/A DTD 04/26/2000, indicating an intent to sell up to 12,000 shares of common stock.
The notice lists an aggregate market value of $409,744.00 for the shares to be sold and states that there were 96,822,799 shares of common stock outstanding. It also reports that the same account sold 4,000 shares on July 1, 2026 and 8,000 shares on June 16, 2026 in prior transactions.
Seacoast Banking Corporation of Florida (SBCF) provided a second‑quarter 2026 update and outlook, reporting net income of $59.5 million, or $0.55 per diluted share, up 87% from the prior quarter and 39% year over year; adjusted net income was $65.8 million, or $0.61 per diluted share.
Net interest income rose to $182.2 million, up 2% sequentially and 42% from a year earlier, with a stable net interest margin of 3.83% and an eight‑basis‑point expansion in core margin excluding acquisition accretion. Loans grew at a 16% annualized pace to $13.1 billion, while deposits increased at a 3.7% annualized rate to $16.8 billion; the cost of deposits edged down to 1.53%. Asset quality remained strong, with net charge‑offs of 0.10% of average loans and an allowance for credit losses of 1.38% of loans, plus an additional 0.98% in unrecognized discounts on acquired loans.
Capital metrics are described as robust, including a Tier 1 capital ratio of 14.3%, tangible equity to tangible assets of 9.3%, and adjusted return on tangible equity of 15.79%. Wealth management assets under management reached $3.2 billion, up 45% year over year, aided by $388 million of new organic assets in the first half of 2026. For full‑year 2026, Seacoast targets 28%–31% adjusted revenue growth, adjusted diluted EPS of $2.48–$2.52 versus $1.84 in 2025, and an adjusted efficiency ratio of 53%–55%, assuming no further Fed funds changes and a stable economic environment.
SEACOAST BANKING CORP OF FLORIDA (SBCF) reported that EVP and Chief Operating Officer Juliette Kleffel exercised 14,831 stock options at an exercise price of $28.69 per share into common stock on 2026-08-27. On the same date, she sold 14,831 common shares at a weighted average price of about $34.31 per share, with individual sale prices ranging from $34.25 to $34.34. After this exercise, she continues to hold a derivative position for 12,635 shares of common stock at an exercise price of $31.15 per share expiring on 2028-04-01.